{"filing":{"accession_number":"0001213900-26-082025","cik":"0001739174","ticker":"PHGE","company_name":"BiomX Inc.","form":"8-K","filing_date":"2026-07-28","report_date":"2026-07-27","primary_document":"ea0299423-8k_biomx.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026082025/ea0299423-8k_biomx.htm"},"events":[{"id":20963,"run_id":18886,"accession_number":"0001213900-26-082025","anchor_item_number":"1.01","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.82,"summary":"BiomX amended a $1.25M promissory note from its April 2026 ZorroNet acquisition, extending the maturity date from July 10 to November 1, 2026, restructuring principal payments into monthly installments, and issuing 800,000 restricted shares as consideration for the extension and waiver of default.","company_name":"BiomX Inc.","ticker":"PHGE","filing_date":"2026-07-28","form":"8-K","submitted_at":null,"items":[{"id":20480,"accession_number":"0001213900-26-082025","item_number":"1.01","item_title":"Entry into a Material Definitive","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.72,"reasoning":"BiomX amended a $1.25M promissory note from its April 2026 ZorroNet acquisition, extending the maturity date from July 10 to November 1, 2026, restructuring principal payments into monthly installments, and issuing 800,000 restricted shares as consideration for the extension and waiver of default. While this is technically an amendment to existing debt rather than a new issuance, the material restructuring of payment terms, waiver of default, and significant equity consideration (800,000 shares) constitute a material modification of the Company's direct financial obligations that would affect investor assessment of liquidity and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T13:16:44.717672+00:00","company_name":"","ticker":null,"filing_date":""},{"id":20481,"accession_number":"0001213900-26-082025","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Item 3.02 explicitly discloses an unregistered sale of equity securities by BiomX Inc., with shares issued under Section 4(a)(2) and/or Regulation S exemptions as restricted securities. The reference to \"Amendment\" and incorporation of Item 1.01 indicates this is part of a material transaction involving equity issuance, which is a classic dilutive capital raise signal at small-cap issuers.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T13:16:44.717672+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":20480,"accession_number":"0001213900-26-082025","item_number":"1.01","item_title":"Entry into a Material Definitive","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.72,"reasoning":"BiomX amended a $1.25M promissory note from its April 2026 ZorroNet acquisition, extending the maturity date from July 10 to November 1, 2026, restructuring principal payments into monthly installments, and issuing 800,000 restricted shares as consideration for the extension and waiver of default. While this is technically an amendment to existing debt rather than a new issuance, the material restructuring of payment terms, waiver of default, and significant equity consideration (800,000 shares) constitute a material modification of the Company's direct financial obligations that would affect investor assessment of liquidity and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T13:16:44.717672+00:00","company_name":"BiomX Inc.","ticker":"PHGE","filing_date":"2026-07-28"},{"id":20481,"accession_number":"0001213900-26-082025","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Item 3.02 explicitly discloses an unregistered sale of equity securities by BiomX Inc., with shares issued under Section 4(a)(2) and/or Regulation S exemptions as restricted securities. The reference to \"Amendment\" and incorporation of Item 1.01 indicates this is part of a material transaction involving equity issuance, which is a classic dilutive capital raise signal at small-cap issuers.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T13:16:44.717672+00:00","company_name":"BiomX Inc.","ticker":"PHGE","filing_date":"2026-07-28"}]}